An Italian company Takis's chief executive officer Luigi Aurisicchio announced that for the first time in the world they have made a COVID-19 candidate vaccine, adding that the vaccine has neutralized the virus in human cells.
Results from test labs have shown that these antibodies that were created in test mice were able to prevent human cells from being infected. Ordinarily, it takes at least five years to develop a vaccine but experts say that period could be shorter in this case.
Tests conducted on mice by a team of scientists at Italian medical firm Takis showed they developed antibodies after a single vaccination that can block the virus from infecting human cells, ANSA reported.
However, for the vaccine to come to fruition, Takis' efforts require support from the Italian government, and partnerships with worldwide bodies.
Except for the DNA-based vaccine attempted by US-based Inovio Pharmaceuticals, all the other vaccines are now undergoing Phase 1 and Phase 2 human trials together, to fast track the development process.
"I think we'll have a vaccine by the end of the year", Trump told the moderators, Fox News' Bret Baier and Martha MacCallum, saying he was "very confident" in the assessment.
GSK will be contributing on its approved adjuvants, which aid in giving a boost to the immune response to produce antibodies and longer-lasting immunity.
This is not the first COVID-19 neutralizing vaccine claim we have come across this week since researchers in Israel also develop an antibody that claims to do the same against COVID-19.
Andy Lack to exit, replaced by Telemundo chief
The office of the NY attorney general did not immediately respond to Fox News' request for comment. Both Conde and Lazarus will report to Shell.
Morning Consult surveyed 2,200 United States adults and said 64% of them will get a vaccine that would protect them from coronavirus. "We expect this to happen in humans too", he added.
'Vaccines already in human trials had already done the groundwork with other versions of the same vaccine or just didn't bother'.
What is the WHO's solidarity trial?
Meanwhile, a team of USA scientists led by US-based Los Alamos National Laboratory (Los Alamos or LANL) have identified that the new strain is more contagious than the virus in early days of the COVID-19 pandemic.
Codagenix Inc: co-developing a live-attenuated vaccine with the Serum Institute of India using viral deoptimization.
The first dosing of the BNT162 vaccine program began in Germany last week, according to a company statement.